UNJHAFORPharmaceuticals
Unjha Formulations Ltd — Profit & Loss Statement
₹20.29
-1.10%
Unjha Formulations Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tax Provision | 0.12 Cr | 0.17 Cr | 0.05 Cr | 0.05 Cr |
| Tax Effect Of Unusual Items | 3766.95 | 0.00 | 0.00 | 0.00 |
| Tax Rate For Calcs | 0.22 | 0.38 | 0.14 | 0.16 |
| Normalized EBITDA | 0.63 Cr | 0.58 Cr | 0.45 Cr | 0.51 Cr |
| Total Unusual Items | 17000.00 | 0.00 | — | — |
| Total Unusual Items Excluding Goodwill | 17000.00 | 0.00 | — | — |
| Net Income From Continuing Operation Net Minority Interest | 0.41 Cr | 0.28 Cr | 0.28 Cr | 0.25 Cr |
| Reconciled Depreciation | 0.10 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr |
| Reconciled Cost Of Revenue | 11.61 Cr | 16.38 Cr | 11.39 Cr | 11.46 Cr |
| EBITDA | 0.63 Cr | 0.58 Cr | 0.45 Cr | 0.51 Cr |
| EBIT | 0.53 Cr | 0.50 Cr | 0.38 Cr | 0.43 Cr |
| Net Interest Income | 0.03 Cr | -0.05 Cr | -0.06 Cr | -0.13 Cr |
| Interest Expense | 81000.00 | 0.05 Cr | 0.05 Cr | 0.13 Cr |
| Interest Income | 0.05 Cr | 38000.00 | 22000.00 | 0.02 Cr |
| Normalized Income | 0.41 Cr | 0.28 Cr | 0.28 Cr | 0.25 Cr |
| Net Income From Continuing And Discontinued Operation | 0.41 Cr | 0.28 Cr | 0.28 Cr | 0.25 Cr |
| Total Expenses | 13.45 Cr | 18.00 Cr | 12.80 Cr | 13.91 Cr |
| Rent Expense Supplemental | 64000.00 | 74000.00 | 32000.00 | — |
| Diluted Average Shares | 0.45 Cr | 0.45 Cr | 0.45 Cr | 0.45 Cr |
| Basic Average Shares | 0.45 Cr | 0.45 Cr | 0.45 Cr | 0.45 Cr |
| Diluted EPS | 0.91 | 0.62 | 0.63 | 0.56 |
| Basic EPS | 0.91 | 0.62 | 0.63 | 0.56 |
| Diluted NI Availto Com Stockholders | 0.41 Cr | 0.28 Cr | 0.28 Cr | 0.25 Cr |
| Net Income Common Stockholders | 0.41 Cr | 0.28 Cr | 0.28 Cr | 0.25 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 0.41 Cr | 0.28 Cr | 0.28 Cr | 0.25 Cr |
| Net Income Including Noncontrolling Interests | 0.41 Cr | 0.28 Cr | 0.28 Cr | 0.25 Cr |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 0.41 Cr | 0.28 Cr | 0.28 Cr | 0.25 Cr |
| Pretax Income | 0.52 Cr | 0.45 Cr | 0.33 Cr | 0.30 Cr |
| Other Non Operating Income Expenses | 0.08 Cr | 73000.00 | 68000.00 | 0.19 Cr |
| Special Income Charges | 17000.00 | 0.00 | — | — |
| Other Special Charges | -17000.00 | — | — | — |
| Net Non Operating Interest Income Expense | 0.03 Cr | -0.05 Cr | -0.06 Cr | -0.13 Cr |
| Total Other Finance Cost | 67000.00 | 30000.00 | 0.01 Cr | 0.01 Cr |
| Interest Expense Non Operating | 81000.00 | 0.05 Cr | 0.05 Cr | 0.13 Cr |
| Interest Income Non Operating | 0.05 Cr | 38000.00 | 22000.00 | 0.02 Cr |
| Operating Income | 0.42 Cr | 0.49 Cr | 0.36 Cr | 0.26 Cr |
| Operating Expense | 1.83 Cr | 1.62 Cr | 1.41 Cr | 2.45 Cr |
| Other Operating Expenses | 0.74 Cr | 0.54 Cr | 0.45 Cr | 1.80 Cr |
| Depreciation And Amortization In Income Statement | 0.10 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr |
| Depreciation Income Statement | 0.10 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr |
| Selling General And Administration | 0.18 Cr | 0.21 Cr | 0.36 Cr | 0.57 Cr |
| Selling And Marketing Expense | 0.11 Cr | 0.14 Cr | 0.15 Cr | 0.30 Cr |
| General And Administrative Expense | 0.07 Cr | 0.08 Cr | 0.21 Cr | 0.28 Cr |
| Rent And Landing Fees | 64000.00 | 74000.00 | 32000.00 | — |
| Gross Profit | 2.25 Cr | 2.11 Cr | 1.77 Cr | 2.71 Cr |
| Cost Of Revenue | 11.61 Cr | 16.38 Cr | 11.39 Cr | 11.46 Cr |
| Total Revenue | 13.86 Cr | 18.50 Cr | 13.15 Cr | 14.16 Cr |
| Operating Revenue | 13.86 Cr | 18.50 Cr | 13.15 Cr | 14.16 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Unjha Formulations Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.